We are happy to announce that the Norwegian family-owned investment company Ferd will come as a co-owner of Aidian together with Nordstjernan
Earlier this year the Swedish family-owned investment company Nordstjernan communicated that they acquired 100% of the shares of Aidian. Through an agreement between Nordstjernan and Ferd dated 8th of April it was decided that Ferd acquires 33% of Aidian’s shares and will thus become a minority owner in Aidian.
"We are happy to get Ferd as a new owner on board, and we are sure we will benefit from their existing expertise within in vitro diagnostics. Ferd owns the healthcare company, Dr Fürst, which is a leading provider of laboratory services to the primary health service in Norway. Together with Nordstjernan and Ferd we are well equipped to continue building our exciting growth path within in vitro diagnostics", says Aidian’s president Juho Himberg.
”The Finnish Aidian has built a leading and global position within point of care diagnostics. Aidian’s instrument and tests is an important part of the solution to meet global challenges related to health. Together with the main owner Nordstjernan we want to develop the company further with the ambition to continue build a leading actor within point of care diagnostics and testing”, says the president at Ferd, Morten Borge.